CorMedix Reports Results of Neutrolin in P-III LOCK-IT-100 Study for Patients with Hemodialysis
Shots:
- The P-III LOCK-IT-100 Study involves assessing of Neutrolin vs heparin as a catheter lock solution in hemodialysis patients
- Th study resulted in reducing the risk of occurrence of catheter-related blood stream infections (CRBSI) by 72%- with safe and efficate results
- Neutrolin is non-antibiotic- antimicrobiaTYUIOl drug indicated for the prevention of bloodstream infections with the usage of catheters- is evaluated in P-III for chronic hemodialysis and has also received FDA’s FT designation
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
